Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-01-22
2008-01-22
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
10413980
ABSTRACT:
Disclosed are compounds of formula (I):wherein R3, R5, R7and R8are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
REFERENCES:
patent: 4107166 (1978-08-01), Mayer et al.
patent: 4260759 (1981-04-01), Mayer et al.
patent: 6340759 (2002-01-01), Ueno et al.
patent: 1 020 445 (2000-07-01), None
patent: WO 99/18077 (1999-04-01), None
patent: WO 9918077 (1999-04-01), None
patent: WO 01/09134 (2001-02-01), None
patent: WO 01/47922 (2001-07-01), None
patent: WO 01/47922 (2001-07-01), None
patent: WO 02/22601 (2001-09-01), None
Ulanova et al., Spleen tyrosine Kinase (SYK) as a Novel Target for Allergic Asthma and Rhinitis, Expert Opin. Ther. Targets 9(5):901-921 (2005).
Cywin et al., Discovery & SAR of Novel [1,6Naphthyridines as Potent Inhibitors of Spleen Tyrosine Kinase (SYK), Bioorganic & Medicinal Chemistry Letters 13:1415-1418 (2003).
LeCointe, Reach-Through Claims, International Pharmaceutical (2002) (also available at: http://www.bakerbotts.com/infocenter/publications/detail.aspx?id=bffe4a7d-5beb-4cf8-a189-15a5f190f0eb).
Silva, Reach Through Claims: Bust or Boon?, Intellectual Property Update (available at: http://www.dorsey.com/publications/legal—detail.aspx?FlashNavID=pubs—legal&pubid= 170565003).
Wermuth et al: “The Practice of Medicinal Chemistry”,“Molecular Variations Based on Isosteric Replacements,”, 1996 Academic Press Limited, pp. 203-237.
Bobko Mark A.
Cywin Charles L.
Des Jarlais Renee L.
Heider Joachim
Jakes Scott E.
Blankinship Thomas C.
Boehringer Ingelheim Pharmaceuticals Inc.
Chandrakumar Nizal S.
Devlin Mary-Ellen M.
Morris Michael P.
LandOfFree
1,6 Naphthyridines useful as inhibitors of SYK kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,6 Naphthyridines useful as inhibitors of SYK kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,6 Naphthyridines useful as inhibitors of SYK kinase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3929218